Saturday, July 21, 2018

Head-To-Head Contrast: Adecoagro (AGRO) & Alico (ALCO)

Adecoagro (NYSE: AGRO) and Alico (NASDAQ:ALCO) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.

Dividends

Get Adecoagro alerts:

Alico pays an annual dividend of $0.24 per share and has a dividend yield of 0.8%. Adecoagro does not pay a dividend.

Volatility & Risk

Adecoagro has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, Alico has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500.

Earnings & Valuation

This table compares Adecoagro and Alico’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Adecoagro $933.18 million 1.09 $9.97 million $0.08 105.00
Alico $129.83 million 2.01 -$9.45 million N/A N/A

Adecoagro has higher revenue and earnings than Alico.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Adecoagro and Alico, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adecoagro 0 2 1 0 2.33
Alico 0 0 0 0 N/A

Adecoagro currently has a consensus price target of $9.00, suggesting a potential upside of 7.14%. Given Adecoagro’s higher probable upside, analysts plainly believe Adecoagro is more favorable than Alico.

Profitability

This table compares Adecoagro and Alico’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Adecoagro 1.29% 1.81% 0.71%
Alico -9.44% -2.23% -0.91%

Institutional and Insider Ownership

36.1% of Adecoagro shares are held by institutional investors. Comparatively, 74.2% of Alico shares are held by institutional investors. 60.1% of Alico shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Adecoagro beats Alico on 8 of the 12 factors compared between the two stocks.

About Adecoagro

Adecoagro S.A., an agricultural company, engages in farming crops and other agricultural products, dairy operations, sugar, ethanol and energy production, and land transformation activities in South America. The company is involved in planting, harvesting, and selling grains, oilseeds, and fibers, including wheat, corn, soybeans, cotton, sunflowers, and others; and providing grain warehousing/conditioning, and handling and drying services to third parties. It also engages in planting, harvesting, processing, and marketing rice; and producing and selling fluid milk and other dairy products. In addition, the company is involved in the cultivation and processing of sugar and ethanol, as well as cogeneration of electricity from sugarcane bagasse; and identification and acquisition of underdeveloped and undermanaged farmland, and realization of value through the strategic disposition of assets. Further, it is involved in leasing approximately 27,216 hectares of pasture land to cattle farmers in Argentina; and coffee plantation in the Rio de Janeiro farm located in Western Bahia to a third party. As of December 31, 2016, the company owned a total of 246,139 hectares, which comprised 19 farms in Argentina, 11 farms in Brazil, and 1 farm in Uruguay; 3 rice processing facilities in Argentina; 2 dairy facilities with approximately 6,880 milking cows in Argentina; 11 grain and rice conditioning and storage plants in Argentina; and 3 sugar and ethanol mills in Brazil with a sugarcane crushing capacity of 11.2 million tons, as well as had a total of 232 MW of installed cogeneration capacity. Adecoagro S.A. was founded in 2002 and is based in Luxembourg.

About Alico

Alico, Inc., together with its subsidiaries, operates as an agribusiness and land management company in the United States. The company operates through three segments: Alico Citrus, Conservation and Environmental Resources, and Other Operations. The Alico Citrus segment engages in planting, owning, cultivating, and/or managing citrus groves to produce fruits for sale to fresh and processed citrus markets; and contracting for the harvesting, marketing, and hauling of citrus. The Conservation and Environmental Resources segment is involved in the activities related to cattle grazing, sod, native plant, and animal sales; and leasing, management, and/or conservation of unimproved native pasture land. The Other Operations segment engages in the activities related to rock mining royalties, oil exploration, and other lines of business; and ownership and/or lease of improved farmland. Alico, Inc. owned approximately 122,000 acres of land located in 12 counties in Florida, which include the Alachua, Charlotte, Collier, DeSoto, Glades, Hardee, Hendry, Highlands, Lee, Martin, Osceola, and Polk. The company was founded in 1960 and is based in Fort Myers, Florida. Alico, Inc. is a subsidiary of 734 Investors, LLC.

Friday, July 20, 2018

Why Philip Morris Earnings Fell Short

Philip Morris International Inc. (NYSE: PM) reported its most recent quarterly results before the markets opened on Thursday. The company said that it had $1.41 in earnings per share (EPS) and $7.73 billion in revenue. The consensus estimates had called for $1.23 in EPS on revenue of $7.53 billion. The same period of last year reportedly had EPS of $1.14 and revenue of $6.92 billion.

During the quarter, the company noted cigarette and heated tobacco unit shipment volume of 201.7 billion, an increase of 0.9%, or 0.6% excluding the net impact of total estimated inventory movements. Overall this includes cigarette shipment volume of 190.7 billion units, down by 2.8 billion units or 1.5%, and heated tobacco unit shipment volume of 11.0 billion units, up by 4.6 billion units, or 73.0%.

Looking ahead to the full year, the company expects to see EPS in the range of $5.02 to $5.12. The consensus estimates are $5.15 in EPS and $30.8 billion in revenue.

Philip Morris increased its regular quarterly dividend by 6.5%, from $1.07 to $1.14, representing an annualized rate of $4.56 per common share.

CEO Andre Calantzopoulos commented:

Our second-quarter earnings highlight the fundamental strength of our business, with positive total volume growth, currency-neutral net revenue growth of more than 8%, driven by higher pricing from our combustible product portfolio, and close to double-digit growth in ex-currency operating income.

Shares of Philip Morris closed Wednesday at $82.15, with a consensus analyst price target of $99.00 and a 52-week trading range of $76.21 to $121.16. Following the announcement, the stock was down about 5% at $77.98 in early trading indications Thursday.

ALSO READ: 4 Tech Companies That Small and Medium Business Rely On the Most

Thursday, July 19, 2018

Why AT&T Stock Fell 17.4% in the 1st Half of 2018

What happened

Shares of AT&T (NYSE:T) reached the half-year mark of 2018 down 17.4%, according to data provided by S&P Global Market Intelligence�.�

T Chart

T data by YCharts

The telecom company saw significant sell-offs stemming from disappointing quarterly results and uncertainty surrounding the Department of Justice's (DOJ) challenge to its acquisition of Time Warner and whether the merger will actually work to its benefit.�

AT&T's logo.

Image source: AT&T.�

So what

AT&T stock climbed at the beginning of February thanks to better-than-expected fourth-quarter earnings and promising guidance. However, the gains were short lived, and the stock gave up all of its post-earnings gains in the next day of trading amid a broader market sell-off. Shares then continued to see significant downward momentum in the middle of March, corresponding with the beginning of the DOJ antitrust suit that would determine the legality the Time Warner merger.

AT&T stock then took another big hit in April following the release of disappointing first-quarter results. Both sales and earnings came in below the market's expectation, prompting the company's valuation to decline by 7% in the day of trading that followed the April 25 earnings release.

The Washington D.C. district court issued its ruling on June 12, approving AT&T's merger with Time Warner without any conditions that could have required the combined company to sell off assets like DirecTV or the Turner networks. However, AT&T shares lost roughly 7% of their value in the next week's trading -- seemingly due to investor concerns that the deal makes the company too debt heavy.

Now what

AT&T's share price has dipped a roughly 2% more since the beginning of July, with sell-offs coming on the heels of recent news that the DOJ would be challenging the Time Warner merger ruling in appeals court. Management has stated that it doesn't see the appeals case changing anything with regard to the merger, but it will cause the company to incur additional legal expenses and put it on the hook for the costs of splitting from Time Warner -- if the ruling is reversed and that winds up being the final decision on the matter.

AT&T's poor stock performance over the last decade and 34-year history of annual dividend growth have created a situation that has the company's dividend yielding roughly 6.3%.^SPX Chart

^SPX data by YCharts

With the company valued at roughly nine times this year's expected earnings, a likely long-term tailwind from the passage of the Tax Cuts and Jobs Act of 2017, and a market position that points to significant opportunities in 5G and the Internet of Things, income-seeking investors willing to weather some uncertainty should consider adding AT&T to their portfolios.

Friday, July 13, 2018

Is Trump Calling The Shots On Trade? Some Think So

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-997034130&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/997034130/960x0.jpg?fit=scale&q; data-height=&q;483&q; data-width=&q;960&q;&g; Hello friends! No one wants a trade war except for maybe Trump and his team of staunch China hawks. In the early stages of battle, they are winning. But for how long is anybody&a;rsquo;s guess. No one wants this to last long enough to get to the answer on whether a trade war with China is winnable. (Photo by TOLGA AKMEN/AFP/Getty Images)

China businesses are as aggravated about the trade war brewing between Beijing and Washington as their U.S. counterparts. But China companies may have more to sweat.

&a;ldquo;Our China partners are surprised and disappointed to see this happening,&a;rdquo; says Jim Sutter, the CEO of the U.S. Soybean Export Council, the main lobbying arm for one of the industries China hit with tariffs. &a;ldquo;They want to keep doing business with us. But they understand they have to follow the lead of their government.&a;rdquo;

Cosco, one of China&a;rsquo;s largest state-owned shippers of soy, will have to pay itself 25% more for importing U.S. beans. Of course, they will go to Brazil, instead. Otherwise, the government-owned shipper will apparently pay the extra duties to ... itself.

Shanghai companies are talking with exchange officials to figure out what&a;rsquo;s at stake. Mainland Chinese equities are in a bear market, despite Thursday&a;rsquo;s gains. The risk of some companies being banned from trading if their stock falls too much is a real possibility should the latest trade threats come to pass.

On Wednesday, investors woke up to $200 billion more of potential tariffs. Chemical imports are on the hit list, with ingredients used in making medicine part of it. Rosemary Gibson, author of the book &l;em&g;China Rx: Exposing the Risks of America&a;rsquo;s Dependence on China for Medicine&l;/em&g; and a senior advisor at the Hastings Center, a biotech ethics research institute in upstate New York, tweeted on Thursday that China&a;rsquo;s government-funded penicillin industry &a;ldquo;wiped out&a;rdquo; U.S. manufacturers of the key antibiotic.

From a market perspective, the trade war is being won by the U.S. The S&a;amp;P is down only 3% since the January 26 high: better than Europe, Japan, Canada and Mexico.

&l;img class=&q;dam-image bloomberg size-large wp-image-42640319&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/42640319/960x0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Wang Shouwen, China&a;rsquo;s vice minister of commerce, at World Trade Organization headquarters in Geneva, Switzerland, on July 11, 2018. China fired back at President Donald Trump&a;rsquo;s latest tariff barrage, saying it won&a;rsquo;t back down in the trade war that was started unilaterally by the U.S. (Photographer: Stefan Wermuth/Bloomberg)

China is facing more pressure than the U.S.

The World Trade Organization is currently conducting its biannual review of China&s;s trade practices. The country is still subject to frequent criticism for allegedly unfair trade practices, such as state subsidies for companies.

Dennis Shea, U.S. ambassador to the WTO, accused China of causing &a;ldquo;serious harm&a;rdquo; by failing to live up to free-trade principles. &a;ldquo;It is clear that the WTO currently does not offer all of the tools necessary to remedy this situation,&a;rdquo; Shea told the WTO yesterday.

China is opening, but the Trump Administration is at least as interested in countering China&a;rsquo;s growth in Asia, where it can challenge U.S. market share, and remedy a decades-old hallowing out of blue-collar manufacturing jobs by tacking on higher prices for Made in China goods. In Trump&s;s world, some of that supply chain might move to the U.S.

A Chinese government advisor, who is familiar with the international trade talks, told the &l;em&g;South China Morning Post&l;/em&g; in an &l;a href=&q;https://www.scmp.com/news/china/diplomacy-defence/article/2154975/china-under-pressure-live-open-market-pledges-us-calls&q; target=&q;_blank&q;&g;article published Thursday&l;/a&g; that China needed to do more to respect WTO principles such as fairness and transparency.

&a;ldquo;China has not opened up enough yet and it does not take complaints by foreign companies very seriously, but the U.S. is too impatient,&a;rdquo; the advisor said.

Last month, &l;em&g;Frontpage&l;/em&g;, an advocacy magazine for mostly Republican causes, said Trump&a;rsquo;s trade tirades weren&a;rsquo;t just bringing countries to the table to rewrite trade rules. It was forcing political powers to nationalism. Even the Democrats here at home are now promoting their own progressive version of economic protectionism. Free traders are in retreat.

&a;ldquo;Trump hates reacting, he loves taking the initiative and forcing others, rivals, competitors, media syndicates or foreign dictators, to react to him,&a;rdquo;&a;nbsp;&l;a href=&q;https://www.frontpagemag.com/fpm/270456/trumps-5-rules-ruling-world-daniel-greenfield&q; target=&q;_blank&q;&g;writes Daniel Greenfield&l;/a&g;, a foreign affairs journalist more known for his attacks on radical Islam than trade. &a;ldquo;When U.K. Foreign Secretary Boris Johnson muttered that there was a &a;lsquo;method to Trump&a;rsquo;s madness,&a;rsquo; that was it. The method is becoming the driving force in an escalating conflict. Instead of reacting to attacks, Trump forces his attackers to react to him. He takes the initiative and leaves his opponents sputtering.&a;rdquo;

Trump is now in the U.K. where S&a;amp;P Global Market Intelligence analyst Chris Rogers thinks the president will call the shots on trade as Theresa May tries protecting her auto and pharmaceuticals market from tariffs.

The U.S. accounted for &a;euro;105 billion of trade with the U.K. in the 12 months to April 30, Eurostat data shows, making it the most important non-EU partner, at 21.6% of the U.K&s;s export market.

&l;img class=&q;dam-image getty size-large wp-image-997069180&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/997069180/960x0.jpg?fit=scale&q; data-height=&q;638&q; data-width=&q;960&q;&g; The interior of The Trump Arms public house, formally named The Jameson, which has embraced the arrival of President Donald Trump for a visit by changing its name and decorating it&a;rsquo;s interior with Trump memorabilia, in West London on July 12, 2018. (Photo by Niklas HALLE&s;N / AFP)

The U.S. also runs a $6.53 billion goods surplus vs. the U.K. over the same period, reducing the likelihood of hostility from President Trump towards striking a deal.

&a;ldquo;Trump is (most) serious about punishing China, (and) is picking on the areas where it would hurt the most,&a;rdquo; says Naeem Aslam, chief market strategist for ThinkMarkets in London and a &l;em&g;Forbes&l;/em&g; columnist &l;a href=&q;https://www.forbes.com/sites/naeemaslam/2018/07/12/trade-war-china-has-five-weapons-at-its-disposal/#237bfa6d5c1d&q;&g;writing on the topic here today.&l;/a&g;&a;nbsp;&a;ldquo;The market still isn&a;rsquo;t factoring in a full trade war.&a;rdquo;

Corporate America is getting antsy.

Yesterday, the biggest lobby for U.S. multinationals in China basically shouted at Trump through a press release, saying &a;ldquo;enough already.&a;rdquo;

&a;ldquo;Enough is enough. We need to stop the needless escalation of a tariff war and start working on solutions that will address the real concerns that American companies have about China&a;rsquo;s intellectual property protection and technology transfer policies,&a;rdquo; &l;a href=&q;https://www.forbes.com/sites/kenrapoza/2018/07/11/china-trade-war-us-companies-trump/#614abda5468a&q;&g;says U.S. China Business Council president John Frisbie.&l;/a&g; &a;ldquo;Those are the right issues to focus on, but tariffs are the wrong way to solve them.&a;rdquo;

Short term, the tariffs may temporarily keep some manufacturing jobs safe and wages rising. Long term is where the pressure points remain, says Cleveland, Ohio-based market research firm Freedonia.

Tariffs on chemicals used in pharmaceuticals will undermine Chinese drugmakers, but the consequences to U.S. patent-holders such as Johnson &a;amp; Johnson, Merck &a;amp; Co. and Pfizer may outweigh the potential benefits, Freedonia report authors wrote in a 21-pager released today.

&l;img class=&q;dam-image getty size-large wp-image-993064214&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/993064214/960x0.jpg?fit=scale&q; data-height=&q;595&q; data-width=&q;960&q;&g; A container delivery truck passes containers stacked at the Port of Long Beach in Long Beach, California, on July 6, 2018, including one from COSCO, the Chinese state-owned shipping and logistics company.&a;nbsp; (Photo by FREDERIC J. BROWN/AFP/Getty Images)

On the other hand, multinationals like Samsung and LG are proving Trump right.

For instance, the average cost of washing machines shot up 17% in the U.S. since April 2018. In June 2018, Credit Suisse upgraded Whirlpool&a;rsquo;s stock from &a;ldquo;neutral&a;rdquo; to &a;ldquo;outperform,&a;rdquo; projecting a strong year for the U.S. manufacturer as a result of the tariffs. LG and Samsung will continue to ramp up U.S. production operations to avoid the tariffs. In fact, both companies have opened or plan to open new U.S. plants this year.

This won&a;rsquo;t be the case for the majority of companies, but it appears to be part of the endgame. In the near term, the Trump Administration holds a better hand. The long term is risky business.

China will survive.

Shanghai &a;amp; Shenzhen indices rose 2.16% and 2.74% respectively Thursday on strong volumes and with a diversity of winners across industries. Only 43 companies fell on the Shanghai Composite Index. China&a;rsquo;s beloved tech stocks led the way, gaining 5% in Shanghai and around 4% in Shenzhen thanks to the once-sanctioned telecom giant ZTE, which rose 25% in Hong Kong and went limit-up by 10% on the Shenzhen.

Why is ZTE doing so well? It&a;rsquo;s absolutely another matter of Trump trade dealers driving China sentiment. ZTE is up because the Commerce Department and ZTE are closing in on an agreement on escrowing $400 million for its breach-of-trade sanctions against Iran and North Korea.

&a;ldquo;Investors cheered what appears to be the company regaining the ability to survive,&a;rdquo; says Brendan Ahern, CIO of China-centric KraneShares, an ETF company in New York. Investors see ZTE&a;rsquo;s survival as a positive signal for future trade talks.&l;/p&g;

Thursday, July 5, 2018

6 Most Important Things in Business Today

China has challenged the United States as a trade war between the two nations begins. According to Reuters:

The United States is ��opening fire�� on the world with its threatened tariffs, China warned on Thursday, saying no one wants a trade war but it will respond the instant U.S. measures go into effect as Beijing ramped up the rhetoric in the heated dispute.

The Trump administration��s tariffs on $34 billion of Chinese imports are due to go into effect at 0401 GMT on Friday, which is just after midday in Beijing.

Chinese telecom firm ZTE is preparing for a resurrection after U.S. officials nearly shut it down. According to The Wall Street Journal:

ZTE Corp. has named a slate of new top executives, including a new chief executive, a person familiar with the matter said, as the Chinese telecom firm presses ahead with its U.S.-mandated leadership purge.

ZTE��s new CEO is Xu Ziyang, the former head of the company��s business in Germany, the person said. The company also named a new chief financial officer, as well as a new chief technology officer and a new head of human resources, the person said.

The new leadership comes less than a week after ZTE��s board of directors resigned and shareholders voted to install a new eight-person board. ZTE is required to name a new board and senior executives as conditions for the U.S. government to lift a ban on purchasing American-made parts.


The world’s largest hedge fund will enter the Chinese market. According to The Wall Street Journal:

Bridgewater Associates LP, the world��s largest hedge-fund firm, has won approval to sell investment products to institutional and high-net-worth investors in China.

Bridgewater (China) Investment Management Co., a Shanghai-based unit of the U.S. firm, obtained a license on June 29 to be a private fund manager, according to the Asset Management Association of China, a quasiofficial body. It has six months to launch its first onshore investment fund.

Some Tesla Inc. (NASDAQ: TSLA) vehicle owners in a European country are not happy with their cars. According to Bloomberg:

Tesla drivers in one of its biggest markets are getting increasingly disgruntled.

Norway��s Consumer Council has seen a rapid increase in complaints coming from Tesla owners, it said in a report dated July 4. Customers have struggled to get in contact with customer service and several have complained about late deliveries, newswire NTB reported earlier.

Germany’s economy is set to slow. According to CNBC:

The International Monetary Fund (IMF) on Thursday cut its 2018 forecast for German GDP growth to 2.2 percent, saying rising protectionism and the threat of a hard Brexit had exposed Europe’s biggest economy to significant short-term risks.

The Washington-based lender, whose previous prediction from April was 2.5 percent, edged its 2019 forecast up to 2.1 percent from 2.0 percent.

While employment is rising in many developed countries, wages are typically a problem. According to CNBC:

A record number of people have jobs, and companies are struggling to fill positions. But workers still aren’t getting raises.

A new report from the Organisation for Economic Co-operation and Development warns that positive employment trends are at risk of being overshadowed by “unprecedented” wage stagnation.

Wednesday, July 4, 2018

Top Biotech Stocks To Watch For 2019

tags:NTAP,CGNT,FCFS,

You can not change a tiger into a kitten by stroking it." - Franklin Delano Roosevelt

Today, we look at a name that has a presentation at the 21st Annual Meeting The American Society of Gene and Cell Therapy that's taking place in Chicago from Wednesday through Saturday this week. Positive data could continue to be a catalyst for the stock. Investors seem to be anticipating this a bit as the stock is running up this week into this presentation. We take a look at this "Tier 4" biotech concern in the paragraphs below.

Company Overview:

Voyager Therapeutics (VYGR) is a Massachusetts-based concern that came public late in 2015. The stock currently has an approximate market cap of just south of $650 million and sells for around $20.00 apiece after this week's early rally. The company is focused on progressing its promising gene therapy candidates through the clinic to commercialization and has chosen as an area of focus neurological diseases that lack safe, effective treatment options.

Top Biotech Stocks To Watch For 2019: NetApp Inc.(NTAP)

Advisors' Opinion:
  • [By Motley Fool Staff]

    NetApp, Inc. (NASDAQ:NTAP)Q4 2018 Earnings Conference CallMay 23, 2018, 5:00 p.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    NetApp (NASDAQ:NTAP) was upgraded by research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued on Friday.

  • [By ]

    On the earnings call, CFO Jim Kavanaugh called IBM's storage performance "disappointing," and blamed a mixture of competition, price pressure and sales execution issues. Rivals such as HP Enterprise (HPE) and NetApp (NTAP) have been reporting stronger storage growth, as industry demand benefits from an Intel  (INTC) server CPU upgrade cycle.

Top Biotech Stocks To Watch For 2019: Cogentix Medical, Inc.(CGNT)

Advisors' Opinion:
  • [By Joseph Griffin]

    News coverage about Vision Sciences (NASDAQ:CGNT) has trended somewhat positive on Friday, Accern reports. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Vision Sciences earned a coverage optimism score of 0.19 on Accern’s scale. Accern also gave news headlines about the medical device company an impact score of 43.7920504117832 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top Biotech Stocks To Watch For 2019: First Cash Financial Services, Inc.(FCFS)

Advisors' Opinion:
  • [By Logan Wallace]

    First Cash Financial Services, Inc. (NYSE:FCFS) shares hit a new 52-week high and low during trading on Thursday . The company traded as low as $88.95 and last traded at $88.70, with a volume of 371494 shares traded. The stock had previously closed at $87.80.

  • [By Joseph Griffin]

    First Cash Financial Services (NYSE: FCFS) and Ferrellgas Partners (NYSE:FGP) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, valuation, earnings, risk, analyst recommendations and profitability.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on First Cash Financial Services (FCFS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com